Equitable Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
17,153
-292
| -2% | -$32.4K | 0.09% | 157 |
|
|
2025
Q1 | $1.95M | Buy |
17,445
+265
| +2% | +$29.7K | 0.11% | 155 |
|
|
2024
Q4 | $1.59M | Sell |
17,180
-424
| -2% | -$39.2K | 0.09% | 164 |
|
|
2024
Q3 | $1.48M | Hold |
17,604
| – | – | 0.09% | 161 |
|
|
2024
Q2 | $1.21M | Buy |
17,604
+1,029
| +6% | +$70.6K | 0.08% | 169 |
|
|
2024
Q1 | $1.21M | Sell |
16,575
-2,494
| -13% | -$183K | 0.08% | 173 |
|
|
2023
Q4 | $1.54M | Sell |
19,069
-483
| -2% | -$39.1K | 0.12% | 140 |
|
|
2023
Q3 | $1.47M | Buy |
19,552
+1,255
| +7% | +$94.1K | 0.12% | 138 |
|
|
2023
Q2 | $1.41M | Buy |
18,297
+484
| +3% | +$37.3K | 0.11% | 144 |
|
|
2023
Q1 | $1.48M | Sell |
17,813
-771
| -4% | -$64K | 0.12% | 142 |
|
|
2022
Q4 | $1.6M | Buy |
+18,584
| New | +$1.6M | 0.13% | 144 |
|
|
2021
Q3 | – | Sell |
-3,446
| Closed | -$237K | – | 367 |
|
|
2021
Q2 | $237K | Buy |
+3,446
| New | +$237K | 0.02% | 333 |
|